PRECISE-DAPT and ARC-HBR Predict in-Hospital Outcomes in Patients Who Underwent Percutaneous Coronary Intervention.

[1]  P. Serruys,et al.  Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial , 2021, Journal of the American Heart Association.

[2]  Samin K. Sharma,et al.  Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. , 2020, Journal of the American College of Cardiology.

[3]  P. Serruys,et al.  Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial. , 2020, The Canadian journal of cardiology.

[4]  M. Price,et al.  Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention , 2019, Circulation.

[5]  S. Yun,et al.  Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy , 2018, Circulation. Cardiovascular interventions.

[6]  Mandeep Singh,et al.  An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.

[7]  John C. Messenger,et al.  Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention: An Updated Report from the National Cardiovascular Data Registry (2007–2012) , 2013, Circulation.

[8]  David J Cohen,et al.  Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. , 2013, JAMA.

[9]  H. Dauerman,et al.  Women, Bleeding, and Coronary Intervention , 2013, Circulation.

[10]  J. Messenger,et al.  Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. , 2012, Journal of the American College of Cardiology.

[11]  S. Pocock,et al.  A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[12]  Sunil V. Rao,et al.  Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[13]  B. Gersh,et al.  Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.

[14]  Adelaide,et al.  Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[15]  R. Califf,et al.  Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. , 2005, The American journal of cardiology.

[16]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[17]  P. Serruys,et al.  Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial. , 2020, JAMA cardiology.

[18]  J. Messenger,et al.  Clinical ResearchInterventional CardiologyThe Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis From the National Cardiovascular Data Registry (2007 to 2011) , 2013 .

[19]  Sunil V. Rao,et al.  Bleeding as a predictor of mortality risk. , 2006, Reviews in cardiovascular medicine.